Licensed Product Supply. As between the Parties, Erasca shall be responsible for, and shall bear the cost of, obtaining (whether by manufacturing or causing to be manufactured) clinical and commercial supplies of the Licensed Product.
Licensed Product Supply. On Licensee’s request in respect of a Licensed Product or component thereof, Licensor agrees to negotiate in good faith to enter into a separate mutually agreed supply agreement for such Licensed Product or component with Licensee generally consistent with the terms set forth in the supply agreement term sheet attached hereto as Schedule 4.5. Without limiting the foregoing, Licensor agrees that Licensee may enter into contracts directly with Licensor’s Third Party manufacturers of the Licensed Products or components thereof, and, upon Licensee’s request and at Licensee’s direction, Licensor will use best efforts to assist Licensee in executing such contracts.
Licensed Product Supply. Following the IND Approval for the first Licensed Product and subject to Sigilon’s supply responsibilities under Section 7.2 and supply rights under Section 7.3.2 (including in the event that Sigilon fails the quality audit to be conducted by Lilly with respect solely to supply of Licensed Product for Phase 1 Clinical Trials under Section 7.2 but not with respect to its continued right to supply Encapsulation Material), Lilly will be responsible for the global supply chain including obtaining sufficient quantities of Islet Cells and final activities associated with encapsulating such Islet Cells with the Encapsulation Material and finishing the Licensed Product, for both clinical and Commercialization purposes. For clarity, the foregoing sentence means that Lilly will work directly with any Cell Line Provider or may identify alternative sources at its own sole discretion.
Licensed Product Supply. Subject to the terms and conditions of this Article 7, Company shall have the right to exercise the License to manufacture Licensed Products for Development or Commercialization in the Field in the Territory itself or to have such Licensed Products manufactured by a Third Party contract manufacturing organization (“CMO”), in each case after successful completion of the Manufacturing Technology Transfer and Qualifying Audits in accordance with Section 7.2. Company may use any Licensed Product manufactured at any such facilities, for Development or Commercialization in the Field in the Territory. All Licensed Products manufactured by or on behalf of Company or its CMO shall be manufactured in compliance with all Applicable Laws and applicable specifications for such Licensed Product.
Licensed Product Supply. The terms of the Parties’ agreement governing MSK’s manufacture and supply of Licensed Products to Licensee of its (and its Affiliates’ and Sublicensees’) requirements for Licensed Products for use in clinical trials during development, are set forth in the Manufacturing Services Agreement entered into by the Parties concurrent with this Agreement (“ Manufacturing Services Agreement ”). [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Licensed Product Supply. The Parties will include an initial supply chain strategy in the Development Plan to ensure adequate supply of clinical supplies for any Clinical Studies to be conducted in accordance with the Development Plan and the Transfer Prices therefor. Such supply chain strategy will be updated by the Parties through the JSC as the Licensed Products progress toward Commercialization. On XPH’s request in respect of a Licensed Product or component thereof, Athenex agrees to negotiate in good faith to enter into a separate mutually agreed supply agreement for such Licensed Product or component with XPH generally consistent with the terms set forth in the supply agreement term sheet attached hereto as Schedule III (Supply). Without limiting the foregoing, Athenex agrees that XPH may enter into contracts directly with Athenex’s contract manufacturing organizations of the Licensed Products or components thereof, and, upon XPH’s request and at XPH’s direction, Athenex will use best efforts to assist XPH in executing such contracts.
Licensed Product Supply. The terms of the Parties' agreement governing MSK's manufacture and supply of Licensed Products to Licensee of its (and its Affiliates' and Sublicensees') requirements for Licensed Products for use in clinical trials during development, are set forth in the Manufacturing Services Agreement entered into by the Parties concurrent with this Agreement (“Manufacturing Services Agreement”).
Licensed Product Supply aaiPharma shall supply, and Salix shall purchase, Licensed Products pursuant to the Supply Agreement.
Licensed Product Supply. Eyenovia shall, unless otherwise agreed to by the Parties, (1) itself, or (2) through a third party with the prior consent of Senju, manufacture and sell the License Product to Senju for any uses under this Agreement, including commercial sales. The price of any API or Licensed Product obtained by Eyenovia from such a third party must be confirmed and agreed to in advance by Senju. The terms and conditions of such sale (including shipping) would be set forth in a separate supply and quality agreement to be negotiated and agreed to in good faith between the Parties, provided however, (1) Senju has the right to require that Eyenovia use API supplied via Senju for its requirements for its manufacture of such Licensed Product; and (2) Senju would reimburse Eyenovia for its actual costs for API required for the manufacture of such Licensed Product. For the purpose of confirmation, Senju would still have to right to separately manufacture or have the Licensed Product manufactured at its discretion for use under the Agreement.
Licensed Product Supply
